PAFs GERMANY

Total # cancer cases (2018)

Total # cancer deaths (2018)

608,742 247,462

26.8%

aPAF, cancer deaths ^bPAF, cancer cases ^cPAF, melanoma cases

TRENDS

Estimated past and future trends in total cases per year (breast and lung) Probability of premature death from cancer per year

INVESTMENT CASE (2019)

*High income

At this income level, investing in a package of essential services and scaling-up coverage will:

Costs per year Projected lives saved per year

BURDEN OF CANCER

46.4%

Total population (2019)

Tobacco (2017)^a Infections (2012)^b

5.5%

Premature deaths from NCDs (2016)

Cancer as % of NCD premature deaths (2016)

8.0%

PAFs

(population attributable fractions)

168,857

Alcohol (2016)^a

Cancer Country Profile 2020

UV (2012)^c Occupational risk (2017)^a

86.0% 6.8%

Obesity (2012)^b

6.2%

GERMANY

83,517,046

11.8%

5.9%

9.5%

2.7%

11.0%

5.2%

2.8%

3.1%

10.3%

2.3%

7.8%

3.6%

11.0%

3.4%

20.4%

1.5%

3.0%

7.7%

6.4%

3.8%

Breast Bladder Colorectum Kidney Lung Melanoma of skin Non-Hodgkin lymphoma Pancreas Prostate Stomach

Most common cancer cases (2018)

Incidence Mortality

0 0 0 0 0 1 1 1 1 1 1

2020 2022 2024 2026 2028 2030

8.84%

8.56%8.46%8.34%8.19%8.08%7.98%7.94%8.07%7.98%7.83%7.75%7.55%7.51%

7.37%

6.99%6.90%6.81%6.72%6.63%6.54%6.45%6.36%6.27%6.18%6.09%6.00%

5.91%

6.86%6.68%6.51%6.34%6.16%5.99%5.82%5.65%5.47%5.30%5.13%4.95%

4.78%

2.00%

7.00%

12.00%

17.00%

2000 2005 2010 2015 2020 2025 2030

Past trends Projected linear trend SDG target 71,623

50,813 71,888

66,749

77,058 80,396

- 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000

Breast cancer Lung cancer

2012 2018 2040

- 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00

2020 2022 2024 2026 2028 2030

US$ (per capita)

HEALTH SYSTEM CAPACITY

aper 10,000 cancer patients

WORKFORCE

aper 10,000 cancer patients

Quality of mortality registration*** 2007-2016 High 2019 yes

# of radiation oncologist^a 2019 n/a

2019 26.1

# of mammographs^a 2020 0.0 # of surgeons^a 2013 901.3

# of CT scanners^a 2020 47.8 # of radiologist^a 2019 163.5

# of MRI scanners^a 2020 46.9 # of nuclear medicine physician^a 2019 16.4

# of PET or PET/CT scanners^a 2020 2.1 # of medical & pathology lab scientists^a n/a n/a

Integrated NCD plan 2019 operational 2019 21.5

NCCP (including cancer types) 2019 operational 2019 4 cancer(s)

MPOWER measures fully implemented and

achieved 2018

1

Cancer management guidelines 2019 yes 2019 generally available

Palliative care included in their operational,

integrated NCD plan 2019 yes

2015-2017 26237

Breast cancer screening program 2019 yes *Defined daily doses for statistical purposes (S-DDD) per miliion inhabitants per day Breast cancer screening program: Starting

age, target population 2019

50

GLOBAL INITIATIVES

Elimination of Cervical Cancer Global Initiative for Childhood Cancer

HPV vaccination programme coverage 2018 31.3 2020 2026

Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 yes

Screening programme type 2019 opportunistic Defined referral system 2019 yes

Screening programme method 2019 PAP smear

Screening participation rates 2019

Early detection programme/guidelines 2019 yes

Defined referral system 2019 yes

70% or more

Annual cancer cases (0-14 years old) Bone marrow transplantation capacity

# Public cancer centres per 10,000 cancer patients

# of treatment services (surgery,

radiotherapy, chemotherapy) 2019 3 Availability of opioids* for pain

management Availability of population-based cancer

registry (PBCR)** 2019

Cancer Country Profile 2020

High quality PBCR

2019 8.9

FORMULATING RESPONSE

# of external beam radiotherapy (photon,electron)^a

GERMANY

Annual cancer cases (0-14 years old) Palliative care availability:

community/home-based care 2019 generally available Available staff in Ministry of Health who

dedicates significant proportion of their time to cancer

# of medical physicist^a

Early detection programme/ guidelines for 4 cancers (breast, cervix, colon, childhood)

469

87

98

1057

Acute lymphoid leukaemia Hodgkin lymphoma Burkitt lymphoma CNS, low grade tumours Retinoblastoma Wilms tumour Other childhood cancer